Author Correction: The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort

Sci Rep. 2020 Nov 13;10(1):20199. doi: 10.1038/s41598-020-77250-4.

Yung-Yeh Su^{1

2

3}, Nai-Jung Chiang^{1

2

3}, Hui-Jen Tsai^{1

2}, Chia-Jui Yen², Yan-Shen Shan^{4

5}, Li-Tzong Chen^{1

2

6}

¹ National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.
² Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
³ Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
⁴ Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan. [email protected].
⁵ College of Medicine, National Cheng Kung University, Tainan, Taiwan. [email protected].
⁶ Department of Internal Medicine, Kaohsiung Medical University Hospital and Kaohsiung Medical University, Kaohsiung, Taiwan.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.